G6PD and G6PD deficiency: In silico and molecular dynamics analyses of the variants revealed significant structural changes, mainly in the structural NADP+ binding site, which could explain the clinical manifestations of G6PD deficiency and open new lines of research to develop new drugs that target these G6PD variants, improving the quality of life of patients.